CStone Pharmaceuticals (HKG:2616)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
8.67
-0.21 (-2.36%)
Aug 19, 2025, 1:45 PM HKT

CStone Pharmaceuticals Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202017 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2020
Cash & Equivalents
457.77387.94996.67558.68742.723,025
Upgrade
Short-Term Investments
232.34331.9551.85588.91913.07536.91
Upgrade
Trading Asset Securities
----122.910.13
Upgrade
Cash & Short-Term Investments
690.1719.881,0491,1481,7793,572
Upgrade
Cash Growth
-19.54%-31.34%-8.63%-35.48%-50.20%23.75%
Upgrade
Accounts Receivable
62.5483.93172.4477.13117.6-
Upgrade
Receivables
62.5483.93172.4477.13117.6-
Upgrade
Inventory
148.85286.1108.8322.1961.36-
Upgrade
Other Current Assets
-----0.72
Upgrade
Total Current Assets
901.491,0901,3301,2471,9583,572
Upgrade
Property, Plant & Equipment
109.99130.54153.37206.57182.866.54
Upgrade
Long-Term Investments
4.859.033.543.483.19-
Upgrade
Other Intangible Assets
155.53161.37173.05159.770.546.51
Upgrade
Other Long-Term Assets
20.062.622.2621.7657.28117.4
Upgrade
Total Assets
1,1921,3931,6621,6382,2713,763
Upgrade
Accounts Payable
212.09338.03246.38290.41414.2928.03
Upgrade
Accrued Expenses
-195.23372.28400.87400.65551.19
Upgrade
Current Portion of Long-Term Debt
19460.8105.998.5730.72.66
Upgrade
Current Portion of Leases
25.9532.4233.3336.3513.258.65
Upgrade
Current Income Taxes Payable
-1.7717.665.8224.296.09
Upgrade
Current Unearned Revenue
10.3910.396.8977.457.21
Upgrade
Other Current Liabilities
183.3843.3767.82197.4642.31123.21
Upgrade
Total Current Liabilities
625.8682.01850.34946.48932.95727.05
Upgrade
Long-Term Debt
169.2257.4213218.99115.8154.34
Upgrade
Long-Term Leases
2.235.3611.1422.3914.4418.21
Upgrade
Long-Term Unearned Revenue
79.6484.8361.971.251.258.7
Upgrade
Other Long-Term Liabilities
--68.73---
Upgrade
Total Liabilities
876.861,0301,2051,1891,064808.29
Upgrade
Common Stock
0.920.860.860.80.80.79
Upgrade
Additional Paid-In Capital
-9,0048,9928,6288,4658,324
Upgrade
Retained Earnings
--9,111-9,020-8,652-7,750-5,830
Upgrade
Treasury Stock
-0-0.01-0.01-0-0.01-0.02
Upgrade
Comprehensive Income & Other
314.13469.99483.25473.09491.44459.09
Upgrade
Total Common Equity
315.04363.87456.83449.331,2072,954
Upgrade
Shareholders' Equity
315.04363.87456.83449.331,2072,954
Upgrade
Total Liabilities & Equity
1,1921,3931,6621,6382,2713,763
Upgrade
Total Debt
391.37355.97363.45286.29174.283.86
Upgrade
Net Cash (Debt)
298.73363.91685.07861.311,6043,488
Upgrade
Net Cash Growth
-42.88%-46.88%-20.46%-46.32%-54.00%21.02%
Upgrade
Net Cash Per Share
0.230.290.540.731.383.33
Upgrade
Filing Date Shares Outstanding
1,3141,2771,2751,1981,1731,147
Upgrade
Total Common Shares Outstanding
1,3141,2771,2751,1981,1731,147
Upgrade
Working Capital
275.69407.9479.45300.441,0252,845
Upgrade
Book Value Per Share
0.240.280.360.381.032.58
Upgrade
Tangible Book Value
159.52202.51283.79289.631,1362,948
Upgrade
Tangible Book Value Per Share
0.120.160.220.240.972.57
Upgrade
Machinery
-13.7914.1119.118.9516.57
Upgrade
Construction In Progress
-151.75151.75151.76138.6721.48
Upgrade
Leasehold Improvements
-21.2821.2821.2820.3119.85
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.